Latest Regulatory News

Island Pharmaceuticals has secured over $1 million through option exercises by directors and major shareholders, bolstering its cash reserves to advance the clinical and regulatory development of its broad-spectrum antiviral, Galidesivir.

Optiscan Imaging Ltd has initiated Australia’s first intra-operative head and neck cancer imaging study using its advanced InVue® and InForm™ devices, aiming to enhance surgical precision and support FDA regulatory submissions.

DPM Metals has announced a substantial inferred mineral resource at its Rakita Camp in Serbia, highlighting 2.6 million ounces of gold and 1.9 billion pounds of copper. This milestone underscores the camp's potential as a district-scale gold-copper system with promising growth prospects.

Rox Resources has opened a $10 million Share Purchase Plan at a 19.9% discount, inviting eligible shareholders to invest in the development of its Youanmi Gold Project. The offer runs through mid-December, aiming to bolster exploration and working capital.

MEC Resources Ltd has announced a placement of over 359 million new options to raise approximately $359,000, with directors participating to offset fees. The offer comes as the company navigates ongoing legal challenges related to its key PEP-11 permit.

Galilee Energy Limited has been reinstated to trading on the ASX following the announcement of a significant capital raising and acquisition, signaling a pivotal moment for the energy explorer.

Galilee Energy has secured an option to acquire the Zydeco Gas Project in Louisiana, marking a strategic expansion into the US market, supported by a A$6.5 million capital raise to accelerate development.

OM Holdings has cleared major regulatory hurdles in the $101 million sale of its 26% stake in Ntsimbintle Mining, moving closer to closing the deal in early 2026.

OM Holdings has secured key regulatory and shareholder approvals for the sale of its 26% interest in Ntsimbintle Mining, moving the $101 million transaction closer to completion early next year.

Proteomics International Laboratories has clarified that no undisclosed information explains its recent share price jump, pointing instead to recent Medicare reimbursement decisions and key product developments.

Brightstar Resources has completed its acquisition of Aurumin Limited, converting Aurumin shares and options into Brightstar securities and prompting Aurumin’s imminent delisting from the ASX.

FireFly Metals has successfully raised over C$30 million through a Canadian bought deal and approximately A$106.5 million via an Australian equity raise to fund key development and exploration at its Green Bay Copper-Gold Project in Newfoundland.